샘플 요청 목록

 카트 문의
시장보고서
상품코드
1790341

미국의 유방 보형물 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 재료 유형별, 용도/적응증별, 유통 채널별, 부문별 예측(2025-2033년)

U.S. Breast Prosthetic Market Size, Share & Trends Analysis Report By Product Type (Full Breast Prosthesis, Partial Breast Prosthesis), By Material Type, By Application/Indication, By Distribution Channel, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 유방 보형물 시장 개요

미국의 유방 보형물 시장 규모는 2024년에 1억 2,175만 달러로 추정되며, 2033년에는 2억 4,111만 달러에 달할 것으로 예측되며, 2025-2033년 CAGR은 7.94%로 성장합니다. 이러한 성장의 배경에는 유방암 발병률 증가, 유방 절제술 시행률 증가, 보철물 재료 및 디자인의 발전, 유방 절제술 후 옵션에 대한 인식 증가, 보험 적용 및 상환 정책의 개선 등이 있습니다.

Breast Cancer Organization에 따르면 2025년에는 약 31만 6,950명의 여성이 침윤성 유방암으로 진단되며, 비침윤성 유관 유관암은 5만 9,080건이 새로 진단될 것으로 예상하고 있습니다. 유방암 여성의 약 16%는 50세 이하입니다.

유방암 연구, 인식 제고 캠페인, 의료 인프라에 대한 투자 증가는 유방 보철물 시장의 주요 촉진요인입니다. 정부기관, 비영리단체, 비상장기업은 조기발견 프로그램, 사회교육, 치료법 개선에 많은 자금을 투입하고 있습니다. 이러한 투자는 조기 진단과 생존율 향상으로 이어져 인공유방과 같은 유방 절제술 후 솔루션에 대한 수요를 증가시키고 있습니다. 또한 자금 지원을 통해 더 진보적이고, 더 편안하고, 심미적으로 사실적인 인공유방 제품을 개발할 수 있게 되어 환자의 만족도와 채택률이 향상되고 있습니다. 또한 의료진을 위한 교육 프로그램을 지원하고, 수술 후 상담을 강화하며, 보철치료에 대한 접근성을 확대하기 위해 노력하고 있습니다. 이러한 구상을 종합하면 유방암 생존자를 위한 보다 협력적인 생태계를 구축하여 미국 시장 성장을 가속하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 미국의 유방 보형물 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 모시장 전망
    • 보조 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장이 해결해야 할 과제 분석
  • 미국의 유방 보형물 시장 분석 툴
    • 산업 분석 - Porter의 산업 분석
    • PESTEL 분석

제4장 미국의 유방 보형물 시장 : 제품 유형별, 추정·동향 분석

  • 부문 대시보드
  • 미국의 유방 보형물 시장 변수 분석
  • 미국의 유방 보형물 시장 규모와 동향 분석(제품 유형별, 2021-2033년)
  • 완전 유방 보형물
  • 부분 유방 보형물(쉐이퍼/쉘)
  • 특수/기능적 의지

제5장 미국의 유방 보형물 시장 : 재료 유형별, 추정·동향 분석

  • 부문 대시보드
  • 미국의 유방 보형물 시장 변수 분석
  • 미국의 유방 보형물 시장 규모와 동향 분석(재료 유형별, 2021-2033년)
  • 실리콘 유방 폼
    • 표준 실리콘
    • 경량 실리콘
  • 폼과 패브릭 유방 폼/비실리콘
  • 기타(커스텀 폴리머 블렌드, 3D 프린팅)

제6장 미국의 유방 보형물 시장 : 용도/적응증별, 추정·동향 분석

  • 부문 대시보드
  • 미국의 유방 보형물 시장 변수 분석
  • 미국의 유방 보형물 시장 규모와 동향 분석(용도/적응증별, 2021-2033년)
  • 유방 절제 후 케어
  • 유방 부분 절제술
  • 유방확대수술(비외과적)
  • 선천성 비대칭성
  • 기타

제7장 미국의 유방 보형물 시장 : 유통 채널별, 추정·동향 분석

  • 부문 대시보드
  • 미국의 유방 보형물 시장 변수 분석
  • 미국의 유방 보형물 시장 규모와 동향 분석(유통 채널별, 2021-2033년)
  • 온라인 소매업체/E-Commerce 플랫폼
  • 소매 약국과 의료용품점
  • 전문점과 란제리 부띠크
  • 직접 판매(제조업체-프로바이더/소비자)
  • 병원 클리닉 영업(조달)

제8장 경쟁 구도

  • 시장 참여 기업의 분류
  • 주요 기업 개요
  • 기업 점유율 분석, 2024년
    • Tiger Aesthetics Medical, LLC
    • Anita international Corporation
    • Nearly Me
    • Allergan(AbbVie)
    • Mentor Worldwide LLC(Johnson & Johnson)
    • Amoena Medizin-Orthopadie-Technik GmbH
    • American Breast Care
    • Elkem
    • Trulife
KSA 25.08.26

U.S. Breast Prosthetic Market Summary

The U.S. breast prosthetic market size was estimated at USD 121.75 million in 2024, and is projected to reach USD 241.11 million by 2033, growing at a CAGR of 7.94% from 2025 to 2033. This growth is attributed to the rising incidence of breast cancer, increasing rates of mastectomy procedures, advancements in prosthetic materials and design, growing awareness regarding post-mastectomy options, and improved insurance coverage and reimbursement policies.

According to the Breast Cancer Organization, in 2025, approximately 316,950 women will be diagnosed with invasive breast cancer, with 59,080 new cases of ductal carcinoma in situ, which is non-invasive. About 16% of women with breast cancer are younger than 50 years of age.

Increasing investment in breast cancer research, awareness campaigns, and healthcare infrastructure is a key driver of the breast prosthetic market. Government bodies, non-profit organizations, and private companies are channeling substantial funds into early detection programs, public education, and improved treatment options. These investments have led to earlier diagnoses and higher survival rates, which in turn raise the demand for post-mastectomy solutions such as breast prostheses. Furthermore, funding has enabled the development of advanced, more comfortable, and aesthetically realistic prosthetic products, enhancing patient satisfaction and adoption. Investments also support training programs for healthcare providers, ensuring better post-surgical counseling and expanding access to prosthetic care. Collectively, these initiatives contribute to a more supportive ecosystem for breast cancer survivors, thereby boosting the market growth in the U.S.

U.S. Breast Prosthetic Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 - 2033. For this study, Grand View Research has segmented the U.S. breast prosthetic market report based on product type, material type, application/indication, distribution channel.

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Full Breast Prosthesis
  • Partial Breast Prosthesis (Shapers/Shells)
  • Specialty/Functional Prosthesis
  • Material Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Silicone breast forms
    • Standard Silicone
    • Lightweight
  • Foam and fabric breast forms/Non-silicone
  • Others (custom polymer blends, 3D printed)
  • Application/Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Post-Mastectomy Care
  • Lumpectomy/Partial Mastectomy
  • Breast Augmentation (Non-Surgical)
  • Congenital Asymmetry
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online Retailers/E-commerce Platforms
  • Retail Pharmacies & Medical Supply Stores
  • Specialty Stores & Lingerie Boutiques
  • Direct Sales (Manufacturer to Provider/Consumer)
  • Hospital & Clinic Sales (Procurement)

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Material Type
    • 1.2.3. Application/Indication
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Prosthetic Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of breast cancer
      • 3.2.1.2. Strong investments in breast cancer research
      • 3.2.1.3. Supportive insurance and reimbursement policies
      • 3.2.1.4. Growing preference for non-surgical reconstruction
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of premium products
      • 3.2.2.2. Discomfort or inconvenience with long-term use
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Expansion of Direct-to-Consumer (DTC) and E-commerce channels
      • 3.2.3.2. Increasing focus on inclusive and aesthetic designs
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Rising competition among industry participants
  • 3.3. U.S. Breast Prosthetic Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast Prosthetic Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Prosthetic Market Movement Analysis
  • 4.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Product Type, 2021 - 2033 (USD Million)
  • 4.4. Full Breast Prosthesis
    • 4.4.1. Full Breast Prosthesis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Partial Breast Prosthesis (Shapers/Shells)
    • 4.5.1. Partial Breast Prosthesis (Shapers/Shells) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Specialty/Functional Prosthesis
    • 4.6.1. Specialty/Functional Prosthesis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Prosthetic Market: Material Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Prosthetic Market Movement Analysis
  • 5.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Material Type, 2021 to 2033 (USD Million)
  • 5.4. Silicone Breast Forms
    • 5.4.1. Silicone Breast Forms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Standard Silicone
      • 5.4.2.1. Standard Silicone Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Lightweight
      • 5.4.3.1. Lightweight Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Foam and Fabric Breast Forms/Non-silicone
    • 5.5.1. Foam and Fabric Breast Forms/Non-silicone Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others (Custom Polymer Blends, 3D Printed)
    • 5.6.1. Others (Custom Polymer Blends, 3D Printed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Prosthetic Market: Application/Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Prosthetic Market Movement Analysis
  • 6.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Application/Indication, 2021 to 2033 (USD Million)
  • 6.4. Post-Mastectomy Care
    • 6.4.1. Post-Mastectomy Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Lumpectomy/Partial Mastectomy
    • 6.5.1. Lumpectomy/Partial Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Breast Augmentation (Non-Surgical)
    • 6.6.1. Breast Augmentation (Non-Surgical) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Congenital Asymmetry
    • 6.7.1. Congenital Asymmetry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast Prosthetic Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Breast Prosthetic Market Movement Analysis
  • 7.3. U.S. Breast Prosthetic Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.4. Online Retailers/E-commerce Platforms
    • 7.4.1. Online Retailers/E-commerce Platforms Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Retail Pharmacies & Medical Supply Stores
    • 7.5.1. Retail Pharmacies & Medical Supply Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Specialty Stores & Lingerie Boutiques
    • 7.6.1. Specialty Stores & Lingerie Boutiques Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Direct Sales (Manufacturer to Provider/Consumer)
    • 7.7.1. Direct Sales (Manufacturer to Provider/Consumer) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Hospital & Clinic Sales (Procurement)
    • 7.8.1. Hospital & Clinic Sales (Procurement) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
  • 8.3. Company Share Analysis, 2024
    • 8.3.1. Tiger Aesthetics Medical, LLC
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Anita international Corporation
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Nearly Me
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Allergan (AbbVie)
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Mentor Worldwide LLC (Johnson & Johnson)
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Amoena Medizin-Orthopadie-Technik GmbH
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. American Breast Care
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Elkem
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Trulife
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제